Stock comparison
PFEvsVTRS
Pfizer IncvsViatris Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
PFE
Pfizer Inc
$26.67
+3.17%
Pharmaceuticals$155.1BNYSE
VTRS
Viatris Inc
$14.75
+26.61%
Pharmaceuticals$15.6BNASDAQ
60-day price, rebased to 100
PFE +3.13% · VTRS +13.72%
Round-by-round
PFE 4·VTRS 2
EdgeVTRS
Valuation upside
-18.10% vs +97.70% to DCF fair value
EdgePFE
Balance-sheet strength
Altman Z 2.15 vs 0.89
EdgePFE
Fundamental quality
Piotroski 6.00 vs 4.00 (of 9)
EdgePFE
Growth + margins
Rule-of-40 12.90 vs 10.00
EdgeVTRS
60-day momentum
+3.13% vs +13.72% price return
EdgePFE
Market-cap liquidity
$155.1B vs $15.6B
Verdict
Across6categories,PFEtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onPFEorVTRS
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.